Attached files
| file | filename |
|---|---|
| 10-K - 10-K - Protagonist Therapeutics, Inc | ptgx-20191231x10k.htm |
| EX-32.1 - EX-32.1 - Protagonist Therapeutics, Inc | ptgx-20191231ex32128912a.htm |
| EX-31.2 - EX-31.2 - Protagonist Therapeutics, Inc | ptgx-20191231ex3125360c1.htm |
| EX-31.1 - EX-31.1 - Protagonist Therapeutics, Inc | ptgx-20191231ex311dfbc23.htm |
| EX-21.1 - EX-21.1 - Protagonist Therapeutics, Inc | ptgx-20191231ex211305722.htm |
| EX-10.25 - EX-10.25 - Protagonist Therapeutics, Inc | ptgx-20191231ex1025844a2.htm |
| EX-4.7 - EX-4.7 - Protagonist Therapeutics, Inc | ptgx-20191231ex4743c3fa2.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-230213, No. 333-213120, No. 333-216532, No. 333-223500 and No. 333-225294) and Form S-3 (No. 333-220314, No. 333-227216 and No. 333-234414) of Protagonist Therapeutics, Inc. of our report dated March 10, 2020 relating to the financial statements, which appears in Protagonist Therapeutics, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019.
/s/ PricewaterhouseCoopers LLP
San Jose, CA
March 10, 2020